| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 106.264 | 169.229 | 191.384 | 199.297 | 220.392 | 246.432 | 234.964 | 230.913 | 203.562 | 187.297 |
| Total Income - EUR | 108.300 | 171.476 | 193.182 | 199.338 | 221.273 | 247.582 | 235.734 | 231.789 | 204.226 | 188.028 |
| Total Expenses - EUR | 103.184 | 162.094 | 185.411 | 203.505 | 223.682 | 247.899 | 235.437 | 233.504 | 219.936 | 205.623 |
| Gross Profit/Loss - EUR | 5.116 | 9.382 | 7.771 | -4.167 | -2.409 | -317 | 297 | -1.715 | -15.710 | -17.595 |
| Net Profit/Loss - EUR | 4.362 | 7.838 | 5.852 | -6.160 | -4.613 | -2.608 | -2.052 | -4.024 | -17.746 | -17.595 |
| Employees | 3 | 3 | 4 | 2 | 3 | 3 | 3 | 3 | 2 | 2 |
Check the financial reports for the company - Totopic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 7.209 | 6.765 | 6.287 | 4.503 | 4.970 | 4.096 | 3.675 | 3.466 | 1.728 | 1.289 |
| Current Assets | 6.390 | 9.334 | 16.360 | 8.906 | 13.140 | 11.247 | 19.230 | 15.957 | 20.605 | 31.026 |
| Inventories | 4.467 | 5.096 | 6.084 | 5.133 | 4.578 | 6.625 | 12.845 | 11.481 | 9.425 | 20.528 |
| Receivables | 642 | 67 | 0 | 134 | 888 | 369 | 785 | 2.059 | 4.787 | 10.359 |
| Cash | 1.281 | 4.171 | 10.275 | 3.639 | 7.674 | 4.253 | 5.600 | 2.417 | 6.393 | 140 |
| Shareholders Funds | 2.998 | 8.462 | 11.866 | 5.488 | 769 | -1.853 | -3.865 | -7.900 | -25.622 | -43.074 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 10.600 | 7.637 | 10.780 | 7.920 | 17.342 | 17.196 | 26.770 | 27.323 | 47.955 | 75.388 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5611 - 5611" | |||||||||
| CAEN Financial Year |
5610
|
|||||||||
Comments - Totopic Srl